IDXX IDEXX Laboratories, Inc.

Price (delayed)

$429.66

Market cap

$36.54B

P/E Ratio

79.86

Dividend/share

N/A

EPS

$5.38

Enterprise value

$37.53B

Sector: Healthcare
Industry: Diagnostics & Research
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: CAG, Water, LPD, and Other. The CAG segment develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services, which are used to manage the health status of livestock and poultry, to improve producer, and to ensure the quality and safety of milk and food. The Other operating segment combines and presents products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.

Highlights

The company's equity has surged by 154% QoQ and by 59% YoY
The quick ratio has soared by 76% QoQ and by 23% YoY
The debt has contracted by 13% from the previous quarter but it has grown by 7% YoY
IDXX's price to earnings (P/E) is 55% higher than its 5-year quarterly average of 51.4 and 47% higher than its last 4 quarters average of 54.3

Key stats

What are the main financial stats of IDXX
Market
Shares outstanding
85.05M
Market cap
$36.54B
Enterprise value
$37.53B
Valuations
Price to earnings (P/E)
79.86
Price to book (P/B)
133.69
Price to sales (P/S)
14.78
EV/EBIT
63.24
EV/EBITDA
54.77
EV/Sales
15.17
Earnings
Revenue
$2.47B
EBIT
$593.44M
EBITDA
$685.26M
Free cash flow
$367.15M
Per share
EPS
$5.38
Free cash flow per share
$4.31
Book value per share
$3.21
Revenue per share
$29.07
TBVPS
$19.61
Balance sheet
Total assets
$1.96B
Total liabilities
$1.69B
Debt
$1.09B
Equity
$272.96M
Working capital
$239.03M
Liquidity
Debt to equity
3.99
Current ratio
1.44
Quick ratio
0.79
Net debt/EBITDA
1.44
Margins
EBITDA margin
27.7%
Gross margin
57.2%
Net margin
18.6%
Operating margin
24%
Efficiency
Return on assets
24.8%
Return on equity
242%
Return on invested capital
31.4%
Return on capital employed
41.8%
Return on sales
24%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDXX stock price

How has the Idexx Laboratories stock price performed over time

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$2.47B
Gross profit
$1.42B
Operating income
$593.01M
Net income
$460.1M
Gross margin
57.2%
Net margin
18.6%
The company's net income rose by 13% YoY and by 5% QoQ
IDXX's operating income is up by 12% YoY and by 5% from the previous quarter
The gross profit has increased by 9% YoY
IDXX's revenue is up by 8% year-on-year

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
P/E
79.86
P/B
133.69
P/S
14.78
EV/EBIT
63.24
EV/EBITDA
54.77
EV/Sales
15.17
IDXX's price to earnings (P/E) is 55% higher than its 5-year quarterly average of 51.4 and 47% higher than its last 4 quarters average of 54.3
The company's EPS rose by 14% YoY and by 6% QoQ
The company's equity has surged by 154% QoQ and by 59% YoY
The P/S is 92% above the 5-year quarterly average of 7.7 and 51% above the last 4 quarters average of 9.8
IDXX's revenue is up by 8% year-on-year

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has shrunk by 69% YoY and by 9% QoQ
Idexx Laboratories's return on invested capital has decreased by 7% YoY
The company's return on sales rose by 4.3% QoQ and by 3.4% YoY
The return on assets rose by 2.1% since the previous quarter

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 16% higher than its total liabilities
The quick ratio has soared by 76% QoQ and by 23% YoY
IDXX's current ratio has surged by 69% since the previous quarter and by 25% year-on-year
The company's equity has surged by 154% QoQ and by 59% YoY
IDXX's debt to equity has shrunk by 66% QoQ and by 33% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.